Pharma-Bio Serv PE Ratio 2012-2026 | PBSV
Current and historical p/e ratio for Pharma-Bio Serv (PBSV) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pharma-Bio Serv PE ratio as of September 16, 2026 is 40.00.
| Pharma-Bio Serv PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-17 | 0.46 | 42.17 | |
| 2026-07-31 | 0.42 | $0.01 | 38.18 |
| 2026-04-30 | 0.50 | $0.00 | 0.00 |
| 2026-01-31 | 0.50 | $0.00 | 0.00 |
| 2025-10-31 | 0.46 | $0.00 | 0.00 |
| 2025-07-31 | 0.52 | $0.00 | 0.00 |
| 2025-04-30 | 0.46 | $-0.01 | 0.00 |
| 2025-01-31 | 0.44 | $-0.02 | 0.00 |
| 2024-10-31 | 0.58 | $-0.03 | 0.00 |
| 2024-07-31 | 0.65 | $-0.04 | 0.00 |
| 2024-04-30 | 0.74 | $0.00 | 0.00 |
| 2024-01-31 | 0.70 | $0.03 | 27.05 |
| 2023-10-31 | 0.58 | $0.06 | 10.15 |
| 2023-07-31 | 0.73 | $0.07 | 10.75 |
| 2023-04-30 | 0.69 | $0.06 | 11.97 |
| 2023-01-31 | 0.90 | $0.05 | 18.04 |
| 2022-10-31 | 0.55 | $0.04 | 12.44 |
| 2022-07-31 | 0.50 | $-0.18 | 0.00 |
| 2022-04-30 | 0.59 | $-0.09 | 0.00 |
| 2022-01-31 | 0.57 | $-0.09 | 0.00 |
| 2021-10-31 | 0.56 | $-0.09 | 0.00 |
| 2021-07-31 | 0.87 | $0.13 | 6.88 |
| 2021-04-30 | 0.70 | $0.06 | 11.99 |
| 2021-01-31 | 0.65 | $0.08 | 8.29 |
| 2020-10-31 | 0.66 | $0.09 | 7.40 |
| 2020-07-31 | 0.51 | $0.10 | 4.95 |
| 2020-04-30 | 0.43 | $0.09 | 4.71 |
| 2020-01-31 | 0.43 | $0.09 | 4.66 |
| 2019-10-31 | 0.41 | $0.09 | 4.54 |
| 2019-07-31 | 0.42 | $0.23 | 1.84 |
| 2019-04-30 | 0.50 | $0.24 | 2.09 |
| 2019-01-31 | 0.48 | $0.20 | 2.38 |
| 2018-10-31 | 0.49 | $0.06 | 8.16 |
| 2018-07-31 | 0.27 | $-0.12 | 0.00 |
| 2018-04-30 | 0.26 | $-0.16 | 0.00 |
| 2018-01-31 | 0.28 | $-0.16 | 0.00 |
| 2017-10-31 | 0.22 | $-0.06 | 0.00 |
| 2017-07-31 | 0.29 | $-0.06 | 0.00 |
| 2017-04-30 | 0.30 | $-0.06 | 0.00 |
| 2017-01-31 | 0.38 | $-0.04 | 0.00 |
| 2016-10-31 | 0.41 | $-0.01 | 0.00 |
| 2016-07-31 | 0.38 | $0.03 | 11.29 |
| 2016-04-30 | 0.36 | $0.06 | 6.07 |
| 2016-01-31 | 0.36 | $0.07 | 4.98 |
| 2015-10-31 | 0.40 | $0.07 | 5.82 |
| 2015-07-31 | 0.43 | $0.08 | 5.33 |
| 2015-04-30 | 0.50 | $0.09 | 5.80 |
| 2015-01-31 | 0.56 | $0.09 | 6.52 |
| 2014-10-31 | 0.54 | $0.10 | 5.33 |
| 2014-07-31 | 0.54 | $0.12 | 4.61 |
| 2014-04-30 | 0.71 | $0.14 | 4.94 |
| 2014-01-31 | 0.87 | $0.19 | 4.61 |
| 2013-10-31 | 0.70 | $0.21 | 3.40 |
| 2013-07-31 | 0.55 | $0.20 | 2.71 |
| 2013-04-30 | 0.43 | $0.21 | 2.08 |
| 2013-01-31 | 0.37 | $0.20 | 1.87 |
| 2012-10-31 | 0.35 | $0.20 | 1.69 |
| 2012-07-31 | 0.36 | $0.19 | 1.85 |
| 2012-04-30 | 0.38 | $0.21 | 1.87 |
| 2012-01-31 | 0.32 | $0.17 | 1.81 |
| 2011-10-31 | 0.34 | $0.14 | 2.40 |
| 2011-07-31 | 0.17 | $0.11 | 1.53 |
| 2011-04-30 | 0.15 | $0.05 | 2.90 |
| 2011-01-31 | 0.15 | $0.03 | 4.58 |
| 2010-10-31 | 0.13 | $0.02 | 7.43 |
| 2010-07-31 | 0.15 | $0.02 | 8.15 |
| 2010-04-30 | 0.15 | $0.01 | 11.62 |
| 2010-01-31 | 0.07 | $0.02 | 3.29 |
| 2009-10-31 | 0.14 | $0.04 | 3.56 |
| 2009-07-31 | 0.13 | $0.05 | 2.68 |
| 2009-04-30 | 0.13 | $0.07 | 1.85 |
| 2008-10-31 | 0.12 | $0.07 | 1.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Consulting Services | $0.009B | $0.009B |
| Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Equifax (EFX) | United States | $19.244B | 19.88 |
| Bureau Veritas Registre De Classification (BVRDF) | France | $14.189B | 0.00 |
| Gartner (IT) | United States | $12.097B | 13.31 |
| Booz Allen Hamilton Holding (BAH) | United States | $9.432B | 11.45 |
| Stantec (STN) | Canada | $7.914B | 17.01 |
| FTI Consulting (FCN) | United States | $4.007B | 17.19 |
| Exponent (EXPO) | United States | $3.234B | 30.50 |
| CBIZ (CBZ) | United States | $2.963B | 14.68 |
| Huron Consulting Group (HURN) | United States | $2.451B | 18.21 |
| Charles River Associates (CRAI) | United States | $1.032B | 19.88 |
| Hackett (HCKT) | United States | $0.273B | 10.88 |
| Information Services (III) | United States | $0.255B | 20.27 |
| Franklin Covey (FC) | United States | $0.201B | 24.74 |
| Accos (ACCL) | Hong Kong, SAR China | $0.040B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.011B | 0.00 |
| ATIF Holdings (AUC) | China | $0.009B | 0.00 |